Join to View Full Profile
2238 Geary BlvdSan Francisco, CA 94115
Phone+1 415-833-3692
Dr. Ragavan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Meera Ragavan is a thoracic medical oncologist at Kaiser Permanente in San Francisco, CA. She completed her fellowship training at UCSF, residency in Internal Medicine at Stanford Health Care and graduated from Stanford University School of Medicine in 2017. She is a health services researcher focused on social and financial needs in cancer patients, access to clinical trials, and real-world outcomes, with publications in notable journals such as JNCI Cancer Spectrum, JCO Oncology Practice, Journal of Thoracic Oncology, and Cancer.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2017 - 2020
Stanford University School of MedicineClass of 2016
Certifications & Licensure
CA State Medical License 2018 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Screening for comprehensive social needs in patients with cancer: a narrative review.Isabel Arana, Raymond Liu, Lawrence Kushi, Erin Hahn, Meera Ragavan
JNCI Cancer Spectrum. 2025-03-03 - 3 citationsConsolidation ALK Tyrosine Kinase Inhibitors Versus Durvalumab or Observation After Chemoradiation in Unresectable Stage III ALK-Positive NSCLC.Amin H Nassar, Ritujith Jayakrishnan, Jamie Feng, Frances Shepherd, Elio Adib
Journal of Thoracic Oncology. 2025-01-01 - Band-Aids Can Still Help Heal: The Role of Patient Financial Assistance Programs in Addressing Financial Toxicity.Meera V Ragavan, Rosa V Mora, Ryan Nipp, Lena E Winestone
JCO Oncology Practice. 2025-01-01
Press Mentions
Drugmakers Limit Cancer Patient Access to Financial LifelineJanuary 16th, 2025
50-80% Elders Suffer from Urinary Incontinence: DocAugust 29th, 2019- Let’s Talk Urinary IncontinenceMarch 9th, 2018
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
